«Ми всі в одному човні, тому обираємо спільнодію»

The participation will allow specialists of the leading national pharmaceutical manufacturer to improve the competencies necessary for the production of drugs based on RNA technology. The project is implemented within…

The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…